SCHEMBL1933571

SCHEMBL1933571

FC(F)(F)c1cccc(Cl)c1I

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 3/20 0.40
HSD11B1 P28845 1/20 0.39
TYK2 P29597 1/20 0.38
NOTUM Q6P988 2/20 0.38
PTGS2 P35354 1/20 0.36
RORC P51449 2/20 0.35
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SLC22A12 Q96S37 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2A6 P11509 1/20 0.35
AR P10275 1/20 0.34
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
AXL P30530 1/20 0.33
KCNN4 O15554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7597167 0.83 ALDH1A1 (0.39) P2RX7HSD11B1KDM4ESMN1; SMN2HSD17B10
SCHEMBL25111152 0.77 CA2 (0.44) HSD11B1PTGS2L3MBTL1CYP1A2CYP2A6
SCHEMBL171713 0.77
SCHEMBL29764291 0.76 P2RX7 (0.52) P2RX7HSD11B1TYK2NOTUMPTGS2
SCHEMBL312929 0.76 P2RX7 (0.52) P2RX7HSD11B1TYK2NOTUMPTGS2
SCHEMBL8499174 0.76 KDM4E (0.37) P2RX7KDM4ESMN1; SMN2HSD17B10L3MBTL1
SCHEMBL5966718 0.75 KCNN4 (0.48) P2RX7HSD11B1TYK2PTGS2L3MBTL1
SCHEMBL117692 0.75 KCNN4 (0.48) P2RX7HSD11B1TYK2PTGS2L3MBTL1
SCHEMBL29467226 0.75 KCNN4 (0.48) P2RX7HSD11B1TYK2PTGS2L3MBTL1
SCHEMBL12327631 0.74 HSD11B1 (0.38) P2RX7HSD11B1PTGS2KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026086794-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF USE THEREOF THE CHINESE UNIVERSITY OF HONG KONG (CN) 2026-04-30 WO disclosed
WO-2023016528-A1 CLASS OF BENZOMORPHOLINE COMPOUNDS, AND PREPARATION METHOD THEREFOR AND USE THEREOF 南京明德新药研发有限公司 2023-02-16 WO disclosed
WO-2023016527-A1 CLASS OF BENZOXAZINE SPIRO COMPOUNDS AND PREPARATION METHOD THEREFOR 南京明德新药研发有限公司 2023-02-16 WO disclosed
US-11345711-B2 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones Impact Therapeutics (Shanghai), Inc (CN) 2022-05-31 US disclosed
US-20200385394-A1 8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES Impact Therapeutics (Shanghai), Inc (CN) 2020-12-10 US disclosed
EP-2332936-B1 PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL CO (JP) 2013-09-04 EP disclosed
US-20110178132-A1 PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2011-07-21 US disclosed
EP-2332936-A1 PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL Sumitomo Chemical Company, Limited (JP) 2011-06-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178132-A1 PYRIDINE COMPOUND AND USE THEREOF FOR PEST CONTROL C5, PRDX1, PRDX4 P2RX7 323/4885HSD11B1 3985/4885TYK2 2161/4885
US-11345711-B2 8,9-dihydroimidazo[1,2-a]pyrimido[5,4-e]pyrimidin-5(6H)-ones WEE1, WEE2, CCNE1 P2RX7 1446/4885HSD11B1 2836/4885TYK2 546/4885
US-20200385394-A1 8,9-DIHYDROIMIDAZO[1,2-a]PYRIMIDO[5,4-e]PYRIMIDIN-5(6H)-ONES WEE1, WEE2, CCNE1 P2RX7 1446/4885HSD11B1 2836/4885TYK2 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.